Skip to main content
Log in

Conservative Surgical and Non-surgical Options in Management of T3 Laryngeal Cancer

  • Head and Neck: Laryngeal Cancer (C Piazza, Section Editor)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

We herein address the most up-to-date findings in the literature in relation to surgical and non-surgical organ preservation strategies aimed at treatment of T3 laryngeal cancer.

Recent Findings

T3 laryngeal cancer represents an advanced stage of neoplastic lesions that poses significant challenges in terms of oncologic outcomes as well as function preservation. In the present form of the TNM staging system, T3 of the larynx includes a wide range of different neoplasms that spread into the visceral (paraglottic and pre-epiglottic) spaces of the organ or tend to infiltrate its cartilaginous framework. A number of therapeutic tools are available for its management and include transoral laser microsurgery, open-neck partial laryngectomies, non-surgical organ preservation strategies (mainly in the form of concurrent chemoradiation), and total laryngectomy with/without complementary (chemo)-radiotherapy according to the postoperative histopathologic evaluation of the surgical specimen.

Summary

No prospective randomized controlled trial has been performed to compare the different options in terms of oncologic and functional outcomes due to the multiple tumor and patient-related variables that should ideally be taken into account. Therefore, lacking precise evidence-based data, the choice among the different therapeutic alternatives, even in the presence of a multidisciplinary head and neck cancer team, is mainly made on the basis of institutional and cultural preferences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2010.

    Google Scholar 

  2. McMullen CP, Smith RV. Treatment/comparative therapeutics: cancer of the larynx and hypopharynx. Surg Oncol Clin N Am. 2015;24:521–45.

    Article  PubMed  Google Scholar 

  3. Breda E, Catarino R, Monteiro E. Transoral laser microsurgery for laryngeal carcinoma: survival analysis in a hospital-based population. Head Neck. 2015;37:1181–6.

    Article  PubMed  Google Scholar 

  4. Hakeem AH, Tubachi J, Pradhan SA. Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with transoral CO2 laser microsurgery. Laryngoscope. 2013;123:1912–7.

    Article  PubMed  Google Scholar 

  5. Lee HS, Chun BG, Kim SW, et al. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope. 2013;123:2670–4.

    Article  PubMed  Google Scholar 

  6. •• Pantazis D, Liapi G, Kostarelos D, et al. Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery. Eur Arch Otorhinolaryngol. 2015;272:1983–90. The Authors describe different 5-year disease-specific survivals and organ preservation rates obtained by TLM in supraglottic (both 91.7%) and glottic pT3 (63.2% and 73.3%, respectively). This underlines the presence of possible stratifications within “good” and “bad” supraglottic T3, while such a category in glottic lesions should be always regarded as a suboptimal clinical scenario for TLM

    Article  PubMed  Google Scholar 

  7. Mendelsohn AH, Kiagiadaki D, Lawson G, et al. CO2 laser cordectomy for glottic squamous cell carcinoma involving the anterior commissure: voice and oncologic outcomes. Eur Arch Otorhinolaryngol. 2015;272:413–8.

    Article  PubMed  Google Scholar 

  8. Garofolo S, Piazza C, Del Bon F, et al. Intraoperative narrow band imaging better delineates superficial resection margins during transoral laser microsurgery for early glottic cancer. Ann Otol Rhinol Laryngol. 2015;124:294–8.

    Article  PubMed  Google Scholar 

  9. Peretti G, Plazza C, Cocco D, et al. Transoral CO2 laser treatment for tis-T3 glottic cancer: the Brescia experience on 595 patients. Head Neck. 2010;32:977–83.

    Article  PubMed  Google Scholar 

  10. Hoffmann C, Hans S, Sadoughi B, et al. Identifying outcome predictors of transoral laser cordectomy for early glottic cancer. Head Neck. 2016;38(Suppl 1):E406–11.

    Article  PubMed  Google Scholar 

  11. •• Canis M, Ihler F, Martin A, et al. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery. Head Neck. 2014;36:652–9. One of the largest series in the literature of T3 laryngeal tumors treated by TLM, describing the oncologic outcomes obtained by such a therapeutic tool and its inherent limitations

    Article  PubMed  Google Scholar 

  12. Canis M, Martin A, Ihler F, et al. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients. Head Neck. 2014;36:859–66.

    Article  PubMed  Google Scholar 

  13. Vilaseca I, Bernal-Sprekelsen M, Him R, et al. Prognostic factors of quality of life after transoral laser microsurgery for laryngeal cancer. Eur Arch Otorhinolaryngol. 2015;272:1203–10.

    Article  PubMed  Google Scholar 

  14. Wilkie MD, Lightbody KA, Lythgoe D, et al. Transoral laser microsurgery for early and moderately advanced laryngeal cancers: outcomes from a single centralised United Kingdom centre. Eur Arch Otorhinolaryngol. 2015;272:695–704.

    Article  PubMed  Google Scholar 

  15. Peretti G, Piazza C, Mora F, et al. Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2016;24:135–9.

    Article  PubMed  Google Scholar 

  16. •• Piazza C, Mangili S, Bon FD, et al. Preoperative clinical predictors of difficult laryngeal exposure for microlaryngoscopy: the Laryngoscore. Laryngoscope. 2014;124:2561–7. The Authors describe an easy and reproducible preoperative assessment protocol (the Laryngoscore) including 11 parameters to predict difficult laryngeal exposure during operative microlaryngoscopy. When the score was <6 favourable laryngeal exposure was observed in 94% of patients. For scores >6 and >9, difficult or impossibile laryngeal exposures were observed in 40% and 67% of patients, respectively

    Article  PubMed  Google Scholar 

  17. Mizrachi A, Rabinovics N, Hilly O, et al. Analysis of failure following transoral laser surgery for early glottic cancer. Eur Arch Otorhinolaryngol. 2014;271:2247–51.

    Article  PubMed  Google Scholar 

  18. Succo G, Peretti G, Piazza C, et al. Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European laryngological society. Eur Arch Otorhinolaryngol. 2014;271:2489–96.

    Article  CAS  PubMed  Google Scholar 

  19. Sixteenth BE, Daniel C. Baker, Jr, memorial lecture. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol. 1991;100:261–7.

    Article  Google Scholar 

  20. Isaacs JH Jr, Slattery WH 3rd, Mendenhall WM, et al. Supraglottic laryngectomy. Am J Otolaryngol. 1998;19:118–23.

    Article  PubMed  Google Scholar 

  21. •• Vilaseca I, Bernal-Sprekelsen M, Blanch JL. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck. 2010;32:929–38. Critical reappraisal of the most limiting factors for adequate management of laryngeal T3 by a transoral approach

    PubMed  Google Scholar 

  22. Rioja E, Blanch JL, Borés A, et al. Clinical significance of granulation tissue after transoral laser microsurgery for glottic cancer. J Laryngol Otol. 2015;129:377–82.

    Article  CAS  PubMed  Google Scholar 

  23. • Peretti G, Piazza C, Penco S, et al. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers. Head Neck. 2016;38:1107–12. Oncologic outcomes obtained by TLM in T3 glottic and supraglottic tumors following a more “conservative” philosophy than that described by other authors in the literature

    Article  PubMed  Google Scholar 

  24. Chevalier D, Laccourreye O, Brasnu D, et al. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106:364–9.

    Article  CAS  PubMed  Google Scholar 

  25. Laccourreye O, Brasnu D, Biacabe B, et al. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck. 1998;20:595–9.

    Article  CAS  PubMed  Google Scholar 

  26. Gallo A, Manciocco V, Simonelli M, et al. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg. 2005;131:620–5.

    Article  PubMed  Google Scholar 

  27. Laudadio P, Presutti L, Dall’olio D, et al. Supracricoid laryngectomies: long-term oncological and functional results. Acta Otorhinolaryngol. 2006;126:640–9.

    Article  Google Scholar 

  28. • Rizzotto G, Crosetti E, Lucioni M, et al. Oncologic outcomes of supratracheal laryngectomy: critical analysis. Head Neck. 2015;37:1417–24. Oncologic outcomes of an innovative “extreme” form of open partial laryngectomy as a conservative surgical alternative to total laryngectomy

    Article  PubMed  Google Scholar 

  29. •• Succo G, Crosetti E, Bertolin A, et al. Benefits and drawbacks of open partial horizontal laryngectomies, part B: intermediate and selected advanced stage laryngeal carcinoma. Head Neck. 2016;38(Suppl 1):E649–57. Oncologic outcomes in one of the largest series in the literature of open partial laryngectomies, focusing on T3-T4 laryngeal tumors

    Article  PubMed  Google Scholar 

  30. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.

    Article  Google Scholar 

  31. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.

    Article  CAS  PubMed  Google Scholar 

  32. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845–52.

    Article  CAS  PubMed  Google Scholar 

  33. Timme DW, Jonnalagadda S, Patel R, et al. Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol. 2015;124:845–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cesare Piazza.

Ethics declarations

Conflict of Interest

Dr. Cesare Piazza and Dr. Alberto Paderno declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Head and Neck: Laryngeal Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piazza, C., Paderno, A. Conservative Surgical and Non-surgical Options in Management of T3 Laryngeal Cancer. Curr Otorhinolaryngol Rep 5, 125–131 (2017). https://doi.org/10.1007/s40136-017-0155-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-017-0155-3

Keywords

Navigation